Endo Health Solutions (NASDAQ:ENDP) had its target price lifted by UBS AG from $50.00 to $63.00 in a research note released on Wednesday morning, Analyst Ratings Network.com reports. They currently have a buy rating on the stock.
Endo Health Solutions (NASDAQ:ENDP) traded up 5.33% during mid-day trading on Wednesday, hitting $60.50. 8,404,229 shares of the company’s stock traded hands. Endo Health Solutions has a 52 week low of $25.01 and a 52 week high of $58.23. The stock has a 50-day moving average of $45.99 and a 200-day moving average of $40.10. The company’s market cap is $6.909 billion.
Endo Health Solutions (NASDAQ:ENDP) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.34 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.11 by $0.23. The company had revenue of $715.00 million for the quarter, compared to the consensus estimate of $695.63 million. During the same quarter last year, the company posted $1.28 earnings per share. Endo Health Solutions’s revenue was down 4.7% compared to the same quarter last year. On average, analysts predict that Endo Health Solutions will post $4.73 earnings per share for the current fiscal year.
A number of other firms have also recently commented on ENDP. Analysts at Susquehanna raised their price target on shares of Endo Health Solutions from $42.00 to $62.00 in a research note to investors on Wednesday. They now have a neutral rating on the stock. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Endo Health Solutions from $48.00 to $65.00 in a research note to investors on Wednesday. They now have an overweight rating on the stock. Finally, analysts at Stifel Nicolaus raised their price target on shares of Endo Health Solutions from $40.00 to $60.00 in a research note to investors on Wednesday. They now have a buy rating on the stock. One analyst has rated the stock with a sell rating, eleven have given a hold rating and ten have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of $47.81.
Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.